Estudo mostra distúrbios no controle glicometabólico agudo e de longo prazo após infecção por SARS-CoV-2.

Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection – Nature Metabolism

Relacionado: Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes? – The Lancet Diabetes & Endocrinology E SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment – Cell Metabolism

Comentário no Twitter

For at least 2 months after COVID-19 in people without #diabetes, glucose regulation can be abnormal, along with insulin resistance and abnormal cytokineshttps://t.co/P1xa0lx2c4 @NatMetabolism @PAOLOFIORINA @FiorinaLab pic.twitter.com/Lu7GDMjzdy

— Eric Topol (@EricTopol) May 25, 2021